ICAM1 and colitis: The authors found that ICAM-1 and, to a greater degree, VCAM-1 antibody blockade significantly attenuated leukocyte adhesion to colonic venules in experimental rat models of 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis.